265 related articles for article (PubMed ID: 36412286)
1. Use of methylene blue dye for lymphatic basin mapping and sentinel lymph node biopsy in breast cancer patients in Enugu, Nigeria.
Okoye CL; Ezeome ER
Niger J Clin Pract; 2022 Nov; 25(11):1805-1811. PubMed ID: 36412286
[TBL] [Abstract][Full Text] [Related]
2. The sensitivity and specificity of methylene blue dye as a single agent in sentinel lymph node biopsy for early breast cancer.
Aimir M; Nasser A; Rokayah J; Hardin M; Sohail M
Med J Malaysia; 2022 Sep; 77(5):552-557. PubMed ID: 36169065
[TBL] [Abstract][Full Text] [Related]
3. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
4. The predictive value of methylene blue dye as a single technique in breast cancer sentinel node biopsy: a study from Dharmais Cancer Hospital.
Brahma B; Putri RI; Karsono R; Andinata B; Gautama W; Sari L; Haryono SJ
World J Surg Oncol; 2017 Feb; 15(1):41. PubMed ID: 28173818
[TBL] [Abstract][Full Text] [Related]
5. Methylene blue dye versus combined dye-radioactive tracer technique for sentinel lymph node localisation in early breast cancer.
Varghese P; Mostafa A; Abdel-Rahman AT; Akberali S; Gattuso J; Canizales A; Wells CA; Carpenter R
Eur J Surg Oncol; 2007 Mar; 33(2):147-52. PubMed ID: 17081723
[TBL] [Abstract][Full Text] [Related]
6. Sentinel lymph node mapping in breast cancer using subareolar injection of blue dye.
Kern KA
J Am Coll Surg; 1999 Dec; 189(6):539-45. PubMed ID: 10589589
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of Methylene Blue Test as Single Technique for Sentinel Lymph Node Biopsy in Early Stages Breast Cancer.
Hermansyah D; Rahayu Y; Azrah A; Pricilia G; Paramita D; Siregar ES; Sufida S; Simarmata A
Asian Pac J Cancer Prev; 2021 Sep; 22(9):2765-2769. PubMed ID: 34582644
[TBL] [Abstract][Full Text] [Related]
8. Methylene blue dye--a safe and effective alternative for sentinel lymph node localization.
Varghese P; Abdel-Rahman AT; Akberali S; Mostafa A; Gattuso JM; Carpenter R
Breast J; 2008; 14(1):61-7. PubMed ID: 18186867
[TBL] [Abstract][Full Text] [Related]
9. The role of sentinel lymph node biopsy with blue dye alone in breast cancer patients with excisional biopsy.
Asoglu O; Ozmen V; Karanlik H; Kecer M; Muzlumznoglu M; Igci A; Parlak M
Acta Chir Belg; 2005; 105(3):291-6. PubMed ID: 16018523
[TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node biopsy for breast cancer using methylene blue dye manifests a short learning curve among experienced surgeons: a prospective tabular cumulative sum (CUSUM) analysis.
East JM; Valentine CS; Kanchev E; Blake GO
BMC Surg; 2009 Jan; 9():2. PubMed ID: 19173714
[TBL] [Abstract][Full Text] [Related]
11. Blue dye versus combined blue dye-radioactive tracer technique in detection of sentinel lymph node in breast cancer.
Radovanovic Z; Golubovic A; Plzak A; Stojiljkovic B; Radovanovic D
Eur J Surg Oncol; 2004 Nov; 30(9):913-7. PubMed ID: 15498633
[TBL] [Abstract][Full Text] [Related]
12. Technical issues and pathologic implications of sentinel lymph node biopsy in early-stage breast cancer patients.
Canavese G; Gipponi M; Catturich A; Vecchio C; Tomei D; Nicoló G; Carli F; Spina B; Bonelli L; Villa G; Buffoni F; Bianchi P; Agnese A; Mariani G
J Surg Oncol; 2001 Jun; 77(2):81-7; discussion 88. PubMed ID: 11398158
[TBL] [Abstract][Full Text] [Related]
13. Initial experience with sentinel node biopsy in breast cancer at the National Cancer Center Hospital East.
Imoto S; Hasebe T
Jpn J Clin Oncol; 1999 Jan; 29(1):11-5. PubMed ID: 10073145
[TBL] [Abstract][Full Text] [Related]
14. The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy.
Brahma B; Putri RI; Sari L; Karsono R; Purwanto DJ; Gautama W; Andinata B; Haryono SJ
J Vis Exp; 2019 Jun; (148):. PubMed ID: 31205300
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph node biopsy for breast cancer: impact of the number of sentinel nodes removed on the false-negative rate.
Wong SL; Edwards MJ; Chao C; Tuttle TM; Noyes RD; Carlson DJ; Cerrito PB; McMasters KM
J Am Coll Surg; 2001 Jun; 192(6):684-9; discussion 689-91. PubMed ID: 11400961
[TBL] [Abstract][Full Text] [Related]
16. [Sentinel lymph node biopsy in breast cancer: value for predicting the status of axillary node].
Su F; Jia W; Li H; Zeng Y; Chen J
Zhonghua Wai Ke Za Zhi; 2000 Oct; 38(10):784-6. PubMed ID: 11832165
[TBL] [Abstract][Full Text] [Related]
17. Sentinel node biopsy versus low axillary sampling in women with clinically node negative operable breast cancer.
Parmar V; Hawaldar R; Nair NS; Shet T; Vanmali V; Desai S; Gupta S; Rangrajan V; Mittra I; Badwe RA
Breast; 2013 Dec; 22(6):1081-6. PubMed ID: 23948301
[TBL] [Abstract][Full Text] [Related]
18. [Efficiency of lymphatic mapping by intradermal injection of vital blue dye for sentinel node identification in T1-2 N0-1 M0 stage breast cancer patients].
Kokhreidze I; Nemsadze G; Gersamia G; Dzagnidze G; Janjalia M
Georgian Med News; 2005 Apr; (121):7-10. PubMed ID: 15908713
[TBL] [Abstract][Full Text] [Related]
19. Sentinel lymph node mapping in early-stage breast cancer: technical issues and results with vital blue dye mapping and radioguided surgery.
Canavese G; Gipponi M; Catturich A; Di Somma C; Vecchio C; Rosato F; Percivale P; Moresco L; Nicolò G; Spina B; Villa G; Bianchi P; Badellino F
J Surg Oncol; 2000 May; 74(1):61-8. PubMed ID: 10861612
[TBL] [Abstract][Full Text] [Related]
20. Comparison between one day and two days protocols for sentinel node mapping of breast cancer patients.
Ali J; Alireza R; Mostafa M; Naser FM; Bahram M; Ramin S
Hell J Nucl Med; 2011; 14(3):313-5. PubMed ID: 22087458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]